The early stage SARS-CoV-2 immune response including antibody kinetics in out of hospital patients with mild COVID-19 symptoms

The early stage SARS-CoV-2 immune response including antibody kinetics in out of hospital patients with mild COVID-19 symptoms - Early stage immune responses against SARS-CoV-2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50008

Enrollment

Registered

2020-05-26

Start date

2020-05-15

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronavirus COVID-19

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age > 18 years; 2. Symptoms associated with a COVID-19 infection; 3. Travelled to an endemic region or have contact with a person who is suspected for/or diagnosed with a COVID-19 infection or had a SARS-CoV-2 positive PCR; 4. Mild COVID-19 symptoms which did not require hospital admittance; 5. No more than 10 days between symptoms associated with a COVID-19 infection and the screening visit.

Exclusion criteria

Exclusion criteria: 1. Language problems precluding the completion of the questionnaire or understanding the informed consent; 2. Likelihood of absence in the next 4 weeks.

Design outcomes

Primary

Measure	Time frame
The geometric mean titres of total and isotype-specific (including IgM, IgG) antibodies in patients with mild COVID-19 symptoms which did not require hospital admittance.	—

Secondary

Measure	Time frame
none.	—

Countries

Netherlands

Outcome results